US2020206408A1PendingUtilityA1

Antithrombogenic hollow fiber membranes and filters

71
Assignee: INTERFACE BIOLOGICS INCPriority: May 15, 2009Filed: Dec 26, 2019Published: Jul 2, 2020
Est. expiryMay 15, 2029(~2.8 yrs left)· nominal 20-yr term from priority
B01D 69/0871B01D 71/441B01D 67/0093B01D 63/022B01D 69/02B29C 48/10B01D 63/023B29L 2023/00B01D 2323/36B01D 69/08A61M 1/3673B29C 48/05B01D 2323/30A61P 13/12A61M 1/3672B29L 2031/731B01D 71/68A61L 33/062B29C 48/00A61M 2202/0413B01D 69/087B01D 71/44
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to extracorporeal blood circuits, and components thereof (e.g., hollow fiber membranes, potted bundles, and blood tubing), including 0.005% to 10% (w/w) surface modifying macromolecule. The extracorporeal blood circuits have an antithrombogenic surface and can be used in hemofiltration, hemodialysis, hemodiafiltration, hemoconcentration, blood oxygenation, and related uses.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A hollow fiber membrane, said hollow fiber membrane comprising a base polymer admixed with from 0.005% to 10% (w/w) surface modifying macromolecule, wherein said hollow fiber membrane is antithrombogenic when contacted with blood. 
     
     
         2 . The hollow fiber membrane of  claim 2 , wherein the thrombi deposition on said surface said hollow fiber membrane is reduced by at least 10% when contacted with blood, wherein said hollow fiber membrane has an operating pressure after 4 hours of use that is reduced by at least 10%, or wherein said hollow fiber membrane reduces adverse advents in a subject receiving blood passing through said hollow fiber membrane. 
     
     
         3 . The hollow fiber membrane of  claim 2 , wherein said base polymer is selected from the group consisting of a polysulfone, a polyacrylonitrile, a cellulose acetate, a cellulose di- or tri-acetate, a polyimide, a poly(methyl methacrylate), a polycarbonate, a polyamide, a polypropylene, and a polyethylene. 
     
     
         4 . The hollow fiber membrane of  claim 3 , wherein said base polymer is a polysulfone selected poly(oxy-1,4-phenylene sulfonyl-1,4-phenyleneoxy-1,4-phenyleneisopropylidene-1,4-phenylene) or polyether sulfone. 
     
     
         5 . The hollow fiber membrane of  claim 1 , further comprising a hydrophilic pore forming agent. 
     
     
         6 . The hollow fiber membrane of  claim 5 , wherein said hydrophilic pore forming agent is selected from polyvinylpyrrolidone, ethylene glycol, alcohols, polypropylene glycol, and polyethylene glycol, or mixtures thereof. 
     
     
         7 . The hollow fiber membrane of  claim 5 , comprising from 80% to 96.5% (w/w) of said base polymer, from 3% to 20% (w/w) of said hydrophilic pore forming agent, and 0.005% to 10% (w/w) of said surface modifying macromolecule. 
     
     
         8 . The hollow fiber membrane of  claim 1 , wherein said surface modifying macromolecule is selected from VII-a, VIII-a, VIII-b, VIII-c, VIII-d, IX-a, X-a, X-b, XI-a, XI-b, XII-a, XII-b, XIII-a, XIII-b, XIII-c, XIII-d, XIV-a, and XIV-b.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.